Seaport Therapeutics Shares Surge 17% After $255 Million IPO

Pharmaceutical company Seaport Therapeutics Inc. saw its shares rise 17% on their first day of trading, following an upsized initial public offering that raised approximately $255 million. The company successfully expanded its IPO beyond initial plans, achieving a significant fundraising milestone. Strong investor demand on the first day of trading drove the share price higher. The upsized offering reflects market confidence in the company's potential. Seaport Therapeutics plans to use the proceeds to support drug development efforts and operational activities. This is not investment advice.

📊 SE — Piyasa Yorumu

■ neutral · 60%

Although the news is positive, the stock price has already risen by 4.2%, pushing the RSI above 70 into overbought territory. While the MACD remains positive, there are insufficient catalysts to sustain the short-term uptrend. The $255 million public offering appears to be priced in, and technical indicators are signaling overbought conditions. Therefore, a sideways move or limited correction can be expected in the near term.

RSI 14

70.3

MACD

1.10

24h Δ

4.21%

Canlı Grafikler